Panelists discuss how therapy sequencing is approached for patients with chronic lymphocytic leukemia (CLL), with a focus on ...

Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...

Amid a new Ebola outbreak in Kampala, Uganda, the World Health Organization has kicked off a vaccine trial. This is the first ...

Oxford Nanopore Technologies PLC ( ($GB:ONT) ) has issued an update. Oxford Nanopore Technologies PLC announced a Share Incentive Plan transaction ...

Are people at risk for bird flu? How can I protect myself? Bird flu’s risk for the general public is still low, with no signs ...

Defining remission is challenging due to imprecise CT/PET scans and genetic heterogeneity of aggressive B-cell lymphomas. Next-generation sequencing tests offer potential for more precise remission ...

TD Cowen downgraded Illumina (ILMN) to Hold from Buy with a price target of $140, down from $177. Accelerating high throughput next-generation ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

KUNMING -- Chinese researchers have recently discovered that unique DNA methylation characteristics in long-lived men grant ...

IIT Madras launches cancer genome database to transform cancer research in India, aiming to identify biomarkers and ...

Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay: Salt Lake City Friday, February 7, 2025, 13:00 Hrs [IST] Myriad Genetics, Inc., a ...

Researchers examine the association between sugar-sweetened beverage intake and gut microbiota-mediated changes that may ...